RXDX - Prometheus Biosciences GAAP EPS of -$0.86 beats by $0.06 revenue of $1.11M beats by $0.65M
2023-05-09 18:02:39 ET
- Prometheus Biosciences press release ( NASDAQ: RXDX ): Q1 GAAP EPS of -$0.86 beats by $0.06 .
- Revenue of $1.11M (-71.7% Y/Y) beats by $0.65M .
For further details see:
Prometheus Biosciences GAAP EPS of -$0.86 beats by $0.06, revenue of $1.11M beats by $0.65M